Ayumi Shibayama

Is Blood Eosinophil Count a Biomarker for Chronic Obstructive Pulmonary Disease in a Real-World Clinical Setting? Predictive Property and Longitudinal Stability in Japanese Patients

K. Nishimura, M. Kusunose, R. Sanda, 2021, Diagnostics.

Development of spray‐freeze‐dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity

T. Okuda, H. Okamoto, Masaki Morishita, 2018, Journal of controlled release : official journal of the Controlled Release Society.

Comparison of Predictive Properties between Tools of Patient-Reported Outcomes: Risk Prediction for Three Future Events in Subjects with COPD

K. Nishimura, M. Kusunose, R. Sanda, 2023, Diagnostics.

Comparison between tools for measuring breathlessness: Cross‐sectional validation of the Japanese version of the Dyspnoea‐12

H. Taniguchi, J. Yorke, T. Ogawa, 2021, The clinical respiratory journal.

Are Fatigue and Pain Overlooked in Subjects with Stable Chronic Obstructive Pulmonary Disease?

K. Nishimura, M. Kusunose, R. Sanda, 2021, Diagnostics.

The Conceptual Independence of Health Status, Respiratory Symptoms and Dyspnea in Chronic Obstructive Pulmonary Disease in Real Clinical Practice

K. Nishimura, M. Kusunose, Kazuhito Nakayasu, 2023, Diagnostics.

Comparison of Disease Severity Classifications of Chronic Obstructive Pulmonary Disease: GOLD vs. STAR in Clinical Practice

M. Kusunose, Kazuhito Nakayasu, Ayumi Shibayama, 2024, Diagnostics.